Live Earnings Conference Call: Pfizer's Q3 2026 earnings call is happening now. NYSE:PFE Pfizer Q3 2026 Earnings Results & Report $30.81 +0.14 (+0.46%) As of 10:04 AM Eastern This is a fair market value price provided by Massive. Learn more. Pfizer beat analyst expectations on both earnings and revenue in its Q3 2026 results, released November 3, 2026. The company reported EPS of $0.87 versus the $0.7350 consensus estimate, while revenue of $16.58 billion topped the $15.85 billion estimate by $731.14 million. Revenue decreased 0.4% year over year. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 3, 2026TimeBefore Market OpensConference Call10:00 AM ET Live Call not available Live EventEarnings Conference CallPfizer Q3 202600:00 / 00:00Live Transcript Follow Audio Pfizer EPS ResultsActual EPS$0.87Consensus EPS $0.7350Beat/MissBeat by +$0.1350One Year Ago EPS$0.87EPS Beat Rate8 of last 8 quartersPfizer Revenue ResultsActual Revenue$16.58 billionExpected Revenue$15.85 billionBeat/MissBeat by +$731.14 millionYoY Revenue Growth-0.40%Conference Call ResourcesSlide DeckPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Pfizer Q3 2026 Earnings FAQ Did Pfizer beat earnings estimates for Q3 2026? Pfizer (NYSE:PFE) reported earnings of $0.87 per share for Q3 2026, beating the consensus estimate of $0.7350. The report was announced on Tuesday, November 3, 2026. What was Pfizer's revenue for Q3 2026? Pfizer reported revenue of $16.58 billion for Q3 2026, against a consensus estimate of $15.85 billion. Pfizer Earnings HeadlinesPfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction3 minutes ago | fool.comPfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction42 minutes ago | fool.comxOn October 3, President Trump invoked 1929, warning of a looming downturn. He repeated the comparison a week later in Tennessee. The IMF calls markets increasingly exposed to a sharp correction. Ray Dalio sees a classic bubble. Peter Schiff says a downturn is coming regardless of the election outcome. For retirees living off savings, that warning carries real weight ahead of November 3.November 3 at 1:00 AM | USA Capital Gold (Ad)Pfizer hikes guidance on solid third quarter, names company vet as new CFO43 minutes ago | msn.comPfizer Just Gained 12% in a Month to a 52-Week High: Take Profits, or Buy More?43 minutes ago | finance.yahoo.comPfizer hikes 2026 outlook despite flat Q3 revenue: names new CFO43 minutes ago | msn.comSee More Pfizer Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Pfizer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pfizer and other key companies, straight to your email. Email Address About PfizerPfizer (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures and commercializes prescription medicines and vaccines. Its research activities span areas including oncology, internal medicine, inflammation and immunology, hospital care, infectious diseases and rare diseases. The company’s portfolio includes medicines such as Eliquis, Ibrance, Prevnar and Vyndaqel, as well as vaccines including Comirnaty, Abrysvo and Prevnar. Pfizer also develops treatments through internal research, licensing agreements and collaborations with other pharmaceutical and biotechnology companies. Founded in Brooklyn, New York, in 1849 by Charles Pfizer and Charles Erhart, Pfizer has grown into an international healthcare company serving patients and healthcare providers in markets around the world. The company is headquartered in New York City and is led by Chairman and Chief Executive Officer Albert Bourla.View Pfizer ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Check Point's Turnaround Could Be Closer Than Investors ThinkAbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestAlphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026Exxon's Refining Profits Soared—Did Chevron Get the Same Windfall?LyondellBasell's Dividend Looks Safer, But a New Risk Could Change ThatUranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts? Upcoming Earnings McDonald's (11/4/2026)DoorDash (11/4/2026)MercadoLibre (11/4/2026)Cenovus Energy (11/4/2026)Aflac (11/4/2026)Allstate (11/4/2026)MetLife (11/4/2026)Manulife Financial (11/4/2026)Cencora (11/4/2026)CVS Health (11/4/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
